Is CBL Really a Melanoma Driver? Variant Interpretation Under Scrutiny in Stage II Disease
Pathologists challenge the designation of CBL as a new driver gene in stage II melanoma, arguing that variant reporting gaps ...
Pathologists challenge the designation of CBL as a new driver gene in stage II melanoma, arguing that variant reporting gaps ...
Researchers in the Netherlands identified the RNA splicing factor SRSF7 as a key regulator of migration, invasion, and lung metastasis ...
A new open-source JavaScript toolkit called mSigSDK brings multi-tool mutational signature analysis, privacy-preserving local computation, and reproducible reporting directly into ...
A common germline insertion within a bifunctional super-enhancer dampens the expression of the cancer-promoting genes LINC00636 and CD47 in breast ...
A comprehensive atlas of STING mutations consolidates genetic, structural, and clinical data to clarify how variants drive autoinflammation, immunodeficiency, and ...
A landmark comparative review finds that Japan, South Korea, China, and Australia have all mastered the technology of cancer genomics, ...
A new Nature study integrates multiple classes of genomic mutations to define the distinct mutational processes that shape prostate cancer ...
A Nature Reviews Cancer review explains how genotype-aware single-cell multi-omics and phylogenetic reconstruction are revealing how mutant clones in healthy ...
A Nature Reviews Cancer review argues that population genetics offers the mathematical framework needed to turn tumour genome sequencing data ...
A new open-source software platform could bring high-resolution chromosome analysis closer to routine cancer care, allowing clinicians to inspect tumor ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine